Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
NCT03133481Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2014
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ropivacaine in postoperative pain, sponsored by University of Alabama at Birmingham. Primary endpoint: Mean Distance Ambulated at 48 hours. Started Oct 2014; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03133481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03133481.